CARDEA BIO
Summary
Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors.
Deals Overview
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
Senior Management
Michel Heitzen
CEO
Michael Heltzen
CEO and Co-founder
Brett Goldsmith
Chief Technology Officer